Research Article
Siglec-15 Silencing Inhibits Cell Proliferation and Promotes Cell Apoptosis by Inhibiting STAT1/STAT3 Signaling in Anaplastic Thyroid Carcinoma
Table 2
The multivariate Cox regression analysis between 23 markers and OS in THCA.
| | HR | 95% CI | value |
| HSPA1B | 3.929 | 1.746-8.839 | 0.001 | CXCL5 | 2.813 | 0.910-8.695 | 0.073 | SIGLEC15 | 6.559 | 0.722-59.565 | 0.095 | COLEC12 | 0.201 | 0.045-0.889 | 0.034 | AZU1 | 7.732 | 1.995-29.961 | 0.003 | APOD | 2.232 | 1.099-4.533 | 0.026 | NFATC2 | 3.250 | 1.035-10.206 | 0.044 | SEMA6B | 8.843 | 2.371-32.983 | 0.001 | AGRP | 9.330 | 2.217-39.260 | 0.002 | BMP8A | 2.086 | 1.12-3.885 | 0.020 | IL20RA | 42.522 | 4.641-38.553 | 0.001 | TGFBR3 | 3.441 | 0.675-17.531 | 0.137 | LRRK2 | 1.488 | 0.864-2.563 | 0.152 | CDKN2A | 3.596 | 1.404-9.209 | 0.008 | GLI1 | 0.020 | 0.001-3.670 | 0.141 |
|
|
Notes: THCA: thyroid cancer; OS: overall survival; HR: hazard ratio; CI: confidence intervals. . |